Phosphorothioate oligodeoxyribonucleotides dissociate from cationic lipids before entering the nucleus

被引:127
作者
Marcusson, EG [1 ]
Bhat, B [1 ]
Manoharan, M [1 ]
Bennett, CF [1 ]
Dean, NM [1 ]
机构
[1] ISIS Pharmaceut, Carlsbad, CA 92008 USA
关键词
D O I
10.1093/nar/26.8.2016
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Antisense oligonucleotides complementary to specific mRNA sequences are widely used inhibitors of gene expression in vitro and in vivo. In vitro cationic lipids have been demonstrated to increase the pharmacological activity of antisense oligonucleotides by increasing cellular uptake and facilitating nuclear accumulation. We have investigated the intracellular fate of oligonucleotide/cationic lipid complexes using fluorescently labeled lipids and oligonucleotides targeted to protein kinase C-alpha. After addition to cells the lipids initially co-localized with the oligonucleotide on the cell surface and in fine punctate structures within the cytoplasm. At later times the oligonucleotide began to accumulate in the nucleus as well as the cytoplasm. In contrast, the cationic lipid remained localized to the cell surface and the cytoplasm and was never found in the nucleus. Expression of protein kinase C-alpha mRNA did not begin to decline until after oligonucleotide was seen in the nucleus. This was also coincident with the transient appearance of a smaller mRNA transcript believed to result from RNase H cleavage of protein kinase C-alpha mRNA. These data suggest that although cationic lipids facilitate uptake of oligonucleotides, the complex must disassociate before the oligonucleotide can gain access to the nucleus and induce degradation of targeted mRNA.
引用
收藏
页码:2016 / 2023
页数:8
相关论文
共 58 条
[1]   PHARMACOKINETICS, BIODISTRIBUTION, AND STABILITY OF OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATES IN MICE [J].
AGRAWAL, S ;
TEMSAMANI, J ;
TANG, JY .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (17) :7595-7599
[2]  
Alahari SK, 1996, MOL PHARMACOL, V50, P808
[3]   BINDING, UPTAKE, AND INTRACELLULAR TRAFFICKING OF PHOSPHOROTHIOATE-MODIFIED OLIGODEOXYNUCLEOTIDES [J].
BELTINGER, C ;
SARAGOVI, HU ;
SMITH, RM ;
LESAUTEUR, L ;
SHAH, N ;
DEDIONISIO, L ;
CHRISTENSEN, L ;
RAIBLE, A ;
JARETT, L ;
GEWIRTZ, AM .
JOURNAL OF CLINICAL INVESTIGATION, 1995, 95 (04) :1814-1823
[4]  
BENNETT CF, 1992, MOL PHARMACOL, V41, P1023
[5]  
BENNETT CF, 1995, DELIVERY STRATEGIES, P223
[6]   ELECTROPORATION ENHANCES C-MYC ANTISENSE OLIGODEOXYNUCLEOTIDE EFFICACY [J].
BERGAN, R ;
CONNELL, Y ;
FAHMY, B ;
NECKERS, L .
NUCLEIC ACIDS RESEARCH, 1993, 21 (15) :3567-3573
[7]   Regulation of in vitro gene expression using antisense oligonucleotides or antisense expression plasmids transfected using starburst PAMAM dendrimers [J].
Bielinska, A ;
KukowskaLatallo, JF ;
Johnson, J ;
Tomalia, DA ;
Baker, JR .
NUCLEIC ACIDS RESEARCH, 1996, 24 (11) :2176-2182
[8]   In vivo fate of phosphorothioate antisense oligodeoxynucleotides: Predominant uptake by scavenger receptors on endothelial liver cells [J].
Bijsterbosch, MK ;
Manoharan, M ;
Rump, ET ;
DeVrueh, RLA ;
vanVeghel, R ;
Tivel, KL ;
Biessen, EAL ;
Bennett, CF ;
Cook, PD ;
vanBerkel, TJC .
NUCLEIC ACIDS RESEARCH, 1997, 25 (16) :3290-3296
[9]   IMPROVED BIOLOGICAL-ACTIVITY OF ANTISENSE OLIGONUCLEOTIDES CONJUGATED TO A FUSOGENIC PEPTIDE [J].
BONGARTZ, JP ;
AUBERTIN, AM ;
MILHAUD, PG ;
LEBLEU, B .
NUCLEIC ACIDS RESEARCH, 1994, 22 (22) :4681-4688
[10]   A VERSATILE VECTOR FOR GENE AND OLIGONUCLEOTIDE TRANSFER INTO CELLS IN CULTURE AND IN-VIVO - POLYETHYLENIMINE [J].
BOUSSIF, O ;
LEZOUALCH, F ;
ZANTA, MA ;
MERGNY, MD ;
SCHERMAN, D ;
DEMENEIX, B ;
BEHR, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (16) :7297-7301